MedTrace Logo

Stool Composition and Stool Characteristics in Healthy Term Infants Fed Human Milk or Infant Formulas

NCT01861600 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 375

Last updated 2013-05-23

No results posted yet for this study

Summary

The primary efficacy objective was to determine and compare stool composition (stool soap and non-soap fatty acids, total fatty acids, minerals, and other stool constituents) among the feeding groups.

Conditions

  • Stool Composition

Interventions

OTHER

S-26 Gold

(13.4 g/L protein) with 100% Fat Blend A

OTHER

S-26 Gold EF1

(13.4 g/L protein) with 60% Fat Blend A and 40% Betapol fat blend

OTHER

S-26 Gold EF2

(13.4 g/L protein) with 60% Fat Blend A and 40% Betapol fat blend, and supplemented with 3.0 g/L oligofructose

OTHER

S-26 Gold EF3

(13.4 g/L protein) with 60% Fat Blend A and 40% Betapol fat blend, and supplemented with 5.0 g/L oligofructose

OTHER

Human Milk

Human Milk

Sponsors & Collaborators

  • Société des Produits Nestlé (SPN)

    lead INDUSTRY

Principal Investigators

  • Maria Rosario Zeta Capeding, MD · JRF Health Center Complex, Muntinlupa City, Philippines

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
7 Days
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-04-30
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Philippines

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01861600 on ClinicalTrials.gov